Tuesday, July 5, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

US Research reveals the role of Heparan Sulfate in Obesity

by Medical Finance
in News
US Research reveals the role of Heparan Sulfate in obesity
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

AMSBIO reports how researchers at the Washington University School of Medicine (St. Louis, USA) have used their 10E4 Heparan Sulfate (HS) antibody in pioneering obesity research to quantify the role of HS in the process of intercellular mitochondria transfer to macrophages.

US Research reveals the role of Heparan Sulfate in obesity

A red-labelled macrophage in white adipose tissue acquirees green mitochondria from neighboring cells, including fat cells. Left, low power to show orientation of the macrophage embedded among massive adipocytes. Right, high power to show a macrophage interacting with and internalizing green mitochondria from other cells in the tissue. Image Credit: Brestoff Labs

In recent published research**, researchers from the Brestoff and Teitelbaum Labs demonstrated that adipose-tissue resident macrophages acquire mitochondria from adjacent adipocytes using HS. This process occurs in healthy conditions but is impaired in obesity. Further they have shown that genetic disruption of mitochondria uptake by macrophages reduces energy expenditure and increases diet-induced obesity in mice, indicating that intercellular mitochondria transfer to macrophages mediates systemic metabolic homeostasis.

Obesity is an increasingly common metabolic disease that affects over 40% of adults and 18% of children and adolescents in the United States and is an independent risk factor for the development of many other disorders such as type 2 diabetes, cardiovascular diseases, and cancer.

Mitochondria are the power plants of cells, and it has long been assumed that they are made in one cell and never leave. We discovered that is not really the case and found that fat cells give some of their mitochondria to an immune cell type called macrophages. In obesity, this transferring of mitochondria between cells goes awry, contributing to faster weight gain and worse metabolism. Using a tool called CRISPR, we screened the entire genome and figured out that cells trade mitochondria using a special type of sugar called heparan sulfate, which we think acts like a loading dock for receiving cargo like mitochondria. When we delete heparan sulfates on macrophages, mice get fat. This suggests to us that it is probably good for cells to trade mitochondria with each other. Our team is now trying to figure out how this mysterious and surprising process of mitochondria transfer works because we believe we can harness this biology to treat some human diseases.”


Professor Jonathan Brestoff, Head of the Group

Dr Wentong Jia, a postdoctoral fellow at the Brestoff lab added “The cell surface expression of heparan sulfate, a glycosaminoglycan required for mitochondria uptake in macrophages, depends on a key glycosyltransferase named EXT1. The 10E4 antibody from AMSBIO has helped us verify that we’ve successfully prevented Heparan Sulfate from being synthesized in cells that lack EXT1.”

I find it fascinating that cells use heparan sulfates to take up mitochondria. I wonder if there’s a correlation between the amount or composition of heparan sulfates and a cell’s ability to efficiently take up mitochondria from other cells. Since the various HS antibodies have unique specificities, the different clones can help us start to attack that question.”


Rocky Giwa, PhD Candidate, Brestoff Lab

AMSBIO offers a comprehensive range of high quality Heparan Sulfate (HS) antibodies from F69-3G10, F58-10E4 and JM403 clones, which are ideal for targeted binding of HS in Heparan Sulfate Proteoglycans (HSPG) research.

Heparan sulfate is a highly sulfated polysaccharide, synthesized as the glycosaminoglycan component of heparan sulfate proteoglycans (HSPGs), that is widely distributed on cell surfaces and basement membranes in mammals. It participates in important biological processes due to it displaying specific interactions with many biologically active proteins. AMSBIO is a leading supplier of high quality Heparan Sulfate antibodies from the important clones (JM403, 10E4 and 3G10), which are ideal tools for investigating the binding of HS in different areas of biological research including infection, cancer, and cell signalling.

For further information on high quality Heparan Sulfate antibodies please visit: https://www.amsbio.com/news/us-research-reveals-the-role-of-heparan-sulfate-in-obesity/

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Covid-19 social distancing: when less is more. Image Credit: eldar nurkovic/Shutterstock

Effectiveness of social distancing on COVID-19 infections and fatalities

by Medical Finance
July 5, 2022
0

In a recent study posted to the Research Square* preprint server researchers evaluated the effectiveness of social distancing measures adopted...

Researchers show how an important inhibitor binds to the A2A receptor

Researchers show how an important inhibitor binds to the A2A receptor

by Medical Finance
July 5, 2022
0

The A2A receptor regulates how vigorously the innate immune system attacks diseased cells. Researchers at the University of Bonn have...

Scientists unravel how blood cells mount the first line of defense against viruses

New method for generating binding proteins solves a long-standing challenge in drug development

by Medical Finance
July 5, 2022
0

A team of scientists has created a powerful new method for generating protein drugs. Using computers, they designed molecules that...

Researchers develop new biopsy technology for profiling multiple tumor microenvironment biomarkers

Researchers discover new pathway for DNA transfer in tumor microenvironment

by Medical Finance
July 5, 2022
0

University of Notre Dame researchers have discovered another way tumor cells transfer genetic material to other cells in their microenvironment,...

Study identifies cellular receptors for alphaviruses shared across mosquitoes, humans, and animals

Saliva tests detect SARS-CoV-2 virus more quickly than nasal swabs

by Medical Finance
July 5, 2022
0

Genetic testing of saliva samples identifies the SARS-CoV-2 virus more quickly than testing of nasal swabs. The research is published...

Scrapping many Covid testing measures is a grave mistake, says London Medical Laboratory

Rutgers researchers use roundworms to unravel how cells communicate with one another

by Medical Finance
July 5, 2022
0

Scientists have long puzzled about a critical way that cells communicate with one another, but Rutgers researchers have used a...

Next Post
Ocean living microbes make oxygen in the dark

Scientists develop antibody test to keep track of immunity to SARS-CoV-2 variants

First patient-derived stem cell model developed for studying oculocutaneous albinism

Fully dynamic kinetic model of a living 'minimal cell' offers insight into basic principles of life

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • ImageForNews 57880 16419733401296598
    Flowmeter Solutions for High-Speed Batch Dosing
  • Study: Vaccination Against SARS-Cov-2 In UK School-Aged Children and Young People Decreases Infection Rates and Reduces COVID-19 Symptoms. Image Credit: Studio Romantic / Shutterstock.com
    Single dose of Pfizer vaccine reduces risk of SARS-CoV-2 infection in kids
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply